☆ 4.8 Article

Peptide delivery of a multivalent mRNA SARS-CoV-2 vaccine

JOURNAL OF CONTROLLED RELEASE (2023)

Related references

Note: Only part of the references are listed.

Review Chemistry, Medicinal

The Storage and In-Use Stability of mRNA Vaccines and Therapeutics: Not A Cold Case

Erik Oude Blenke et al.

Summary: The impact of mRNA vaccines on disease mitigation and public health during the COVID-19 pandemic has been significant. However, the stability limitations of mRNA require frozen storage. This review explores the advancements in improving mRNA stability and discusses strategies for design, formulation, and analytical control to enhance storage and in-use stability.

JOURNAL OF PHARMACEUTICAL SCIENCES (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice

Suzanne M. Scheaffer et al.

Summary: Bivalent vaccines induce broad immune responses against SARS-CoV-2 and its variants, offering a customizable approach to protect against COVID-19 as new strains emerge.

NATURE MEDICINE (2023)

Add to Collection

Review Biochemical Research Methods

Principles for designing an optimal mRNA lipid nanoparticle vaccine

Edo Kon et al.

Summary: mRNA lipid nanoparticles (LNPs) have gained significant attention as therapeutic platforms due to the success of the SARS-CoV-2 mRNA LNP vaccines. The modularity and rapid manufacturing capabilities are the advantages of mRNA-LNP vaccines. When designing optimal mRNA-LNPs, choices regarding efficacy, stability, and toxicity need to be made.

CURRENT OPINION IN BIOTECHNOLOGY (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement

Mariona Estape Senti et al.

Summary: In this study, the consequences and mechanisms of complement activation by anti-PEG antibodies interacting with various types of PEGylated lipid-based nanoparticles were investigated. The activation of complement by anti-PEG antibodies can compromise the integrity of nanoparticles, leading to premature drug release or exposure to serum proteins. The levels of pre-existing anti-PEG IgM antibodies in plasma of healthy donors correlated with the degree of complement activation induced upon exposure to PEGylated liposomes and mRNA LNPs.

JOURNAL OF CONTROLLED RELEASE (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Principles for optimization and validation of mRNA lipid nanoparticle vaccines against COVID-19 using 3D bioprinting

Massimiliano Papi et al.

Summary: BioNTech/Pfizer's Comirnaty and Moderna's SpikeVax vaccines are mRNA encapsulated in lipid nanoparticles (LNPs). These vaccines are the result of decades of intense research, but their modular delivery platform and manufacturing possibilities provided by microfluidics have made them an instant success. There are many considerations to be made when designing optimal mRNA-LNPs vaccines. Researchers envision the development of 3D bioprinted validation systems as a faster, cheaper, and more predictive alternative to animal models for vaccine testing.

NANO TODAY (2022)

Add to Collection

Article Medicine, Research & Experimental

Design and lyophilization of lipid nanoparticles for mRNA vaccine and its robust immune response in mice and nonhuman primates

Yuta Suzuki et al.

Summary: mRNA and lipid nanoparticles have been studied as effective vaccine preparation systems against SARS-CoV-2 infection. However, the relationship between lipid nanoparticle composition and activity is not fully understood. In this study, researchers screened a panel of ionizable lipids and identified lipid nanoparticles with a branched-tail lipid structure as the most promising. Through buffer optimization and lyophilization, the mRNA vaccine was successfully stored and induced strong immune responses in mice and nonhuman primates, showing broad antibody activity against various virus strains.

MOLECULAR THERAPY-NUCLEIC ACIDS (2022)

Add to Collection

Article Immunology

Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern

Juan Shi et al.

Summary: This study evaluated the neutralizing activity and protection provided by a BA1-S subunit vaccine in combination with or as a booster dose after administration of wild-type S protein. The results showed that the vaccine elicited high levels of neutralizing antibodies and provided protection against multiple SARS-CoV-2 variants and related coronaviruses. This provides useful guidance for developing effective vaccines to control the COVID-19 pandemic.

NPJ VACCINES (2022)

Add to Collection

Article Medicine, General & Internal

Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies

Alexander Wilhelm et al.

Summary: The Omicron variants of SARS-CoV-2 have become dominant globally, leading to reduced efficacy of current vaccines and monoclonal antibodies. Booster doses can enhance neutralizing capacity against Omicron variants, but waning immunity may result in weaker neutralization. Omicron variants BA.1 and BA.2 exhibit resistance to certain monoclonal antibodies, highlighting the importance of genotype-surveillance and tailored treatment approaches.

EBIOMEDICINE (2022)

Add to Collection

Article Medicine, Research & Experimental

Lipid nanoparticles for delivery of RNA therapeutics Current status and the role of in vivo imaging

Han Na Jung et al.

Summary: Lipid nanoparticles (LNPs) are successful nano-delivery vehicles for cytotoxic chemotherapy agents, antibiotics, and nucleic acid therapeutics. The LNP-based COVID-19 mRNA vaccines from Pfizer/BioNTech and Moderna have achieved great success and resulted in significant sales. LNPs are now being explored for RNA therapeutics in vaccines and treatments for genetic diseases and cancers. Imaging techniques can evaluate the effects of LNPs on pharmacokinetics and pharmacodynamics, accelerating the development of LNP-based mRNA therapies.

THERANOSTICS (2022)

Add to Collection

Article Immunology

Naturally occurring spike mutations influence the infectivity and immunogenicity of SARS-CoV-2

Qiaoli Peng et al.

Summary: This study found that spike mutations in SARS-CoV-2 variants can enhance viral transmissibility and immune evasion, affecting vaccine immunogenicity. Designing vaccines targeting these variants is crucial to overcome immune evasion from current vaccines and neutralizing antibodies.

CELLULAR & MOLECULAR IMMUNOLOGY (2022)

Add to Collection

Letter Virology

On the Calculation of TCID50 for Quantitation of Virus Infectivity

Chengfeng Lei et al.

VIROLOGICA SINICA (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

Density of surface charge is a more predictive factor of the toxicity of cationic carbon nanoparticles than zeta potential

Maud Weiss et al.

Summary: This study clearly demonstrates that the surface charge density of a cationic carbon NP rather than the absolute value of its zeta-potential is a relevant descriptor of its in vitro and in vivo toxicity. The study found that among the cationic carbon NPs examined, only NP5 and NP6 with the highest surface charge density induced significant oxidative stress, IL-8 release, mitochondrial dysfunction, and loss in lysosomal integrity in cells. Additionally, NP5 and NP6 were the only NPs to induce airway inflammation in mice, with NP5 also increasing allergen-induced immune response, airway inflammation, and mucus production.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

Add to Collection

Article Cell Biology

Endosomal escape of delivered mRNA from endosomal recycling tubules visualized at the nanoscale

Prasath Paramasivam et al.

JOURNAL OF CELL BIOLOGY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

mRNA vaccine for cancer immunotherapy

Lei Miao et al.

Summary: mRNA vaccines have emerged as a promising platform for cancer immunotherapy, showcasing high potency, safe administration, rapid development potentials, and cost-effective manufacturing. However, challenges such as stability, innate immunogenicity, and inefficient in vivo delivery restrict their applications. In addressing these challenges, structural modifications and formulation methods are being researched to enhance the anti-tumor immune response.

MOLECULAR CANCER (2021)

Add to Collection

Article Multidisciplinary Sciences

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

Annette B. Vogel et al.

Summary: The two vaccine candidates, BNT162b1 and BNT162b2, developed contain modified messenger RNA encoding immunogens derived from the spike glycoprotein of SARS-CoV-2. They have shown promising immune responses in mice and rhesus macaques, with ongoing phase I trials in Germany and the USA and a global phase II/III trial for BNT162b2.

NATURE (2021)

Add to Collection

Article Virology

Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week

Paloma Troyano-Hernaez et al.

Summary: Monitoring the genetic diversity and mutations of SARS-CoV-2 is crucial for understanding its evolution and ensuring the effectiveness of diagnostic tests, vaccines, and therapies against COVID-19. This study analyzed over 100,000 worldwide SARS-CoV-2 sequences and found significant amino acid changes in the structural proteins, highlighting the importance of ongoing surveillance and research on emerging mutations.

VIRUSES-BASEL (2021)

Add to Collection

Article Multidisciplinary Sciences

An ionizable lipid toolbox for RNA delivery

Xuexiang Han et al.

Summary: In recent years, RNA therapeutics has seen significant growth, largely due to decades of research on lipid nanoparticles, particularly its key component - ionizable lipid. This commentary discusses the major types of ionizable lipids and offers perspectives for future development.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Multidisciplinary Sciences

A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems

Meredith Packer et al.

Summary: The study identified interactions between lipid impurities and mRNA through LNP delivery systems, resulting in impurities that cannot be translated, reducing vaccine efficiency.

NATURE COMMUNICATIONS (2021)

Add to Collection

Review Pharmacology & Pharmacy

mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability

Linde Schoenmaker et al.

Summary: The current mRNA-lipid nanoparticle COVID-19 vaccines require storage at low temperatures due to instability. Improving mRNA nucleotide composition, understanding the impact of mRNA environment within LNPs, and exploring drying techniques can enhance vaccine stability.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)

Add to Collection

Article Immunology

mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents

Susanne Rauch et al.

Summary: mRNA technologies have shown clinical efficacy against COVID-19, with the CVnCoV vaccine demonstrating strong immune responses and protection against SARS-CoV-2 in preclinical studies. Overall, CVnCoV represents a potent and safe candidate for a COVID-19 vaccine.

NPJ VACCINES (2021)

Add to Collection

Review Respiratory System

The immune response to SARS-CoV-2 and COVID-19 immunopathology -- Current perspectives

J. L. Boechat et al.

Summary: SARS-CoV-2 is a new beta coronavirus responsible for COVID-19, declared a pandemic by the World Health Organization. Control of the pandemic has been hindered by limited knowledge of the virus-host interactions. The rapid clinical course of COVID-19 is linked to innate immune response in asymptomatic or mild cases.

PULMONOLOGY (2021)

Add to Collection

Review Medicine, Research & Experimental

Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines

Despo Chatzikleanthous et al.

Summary: Despite the progress in vaccine adjuvants, there are still unmet needs for vaccines against challenging pathogens like HIV, tuberculosis, and cancer. Liposomes have shown to be effective as adjuvant/delivery systems and have potential for further use in vaccine development, as seen in recent COVID-19 vaccines. This review outlines different approaches for lipid-based vaccine adjuvant/delivery systems and how they can be combined to develop multicomponent vaccines.

MOLECULAR PHARMACEUTICS (2021)

Add to Collection

Article Multidisciplinary Sciences

BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans

Ugur Sahin et al.

Summary: The BNT162b2 vaccine shows 95% efficacy in preventing COVID-19 by boosting neutralizing antibody titres and activating specific T cell responses. The vaccine-induced immune response is broad and stable, lasting for a prolonged period, providing good coverage against various SARS-CoV-2 variants.

NATURE (2021)

Add to Collection

Article Medicine, General & Internal

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

Yinon M. Bar-On et al.

Summary: After receiving a third dose of the BNT162b2 mRNA vaccine, Israeli residents aged 60 and above who had previously received two doses of the vaccine saw significantly lower rates of confirmed Covid-19 infection and severe illness compared to those who did not receive a booster shot, indicating the effectiveness of the booster dose in reducing infection and severe illness.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

H. M. El Sahly et al.

Summary: The mRNA-1273 vaccine demonstrated high efficacy in preventing COVID-19 illness and severe disease, with more than 5 months of protection and a good safety profile, including protection against asymptomatic infection.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months

S. J. Thomas et al.

Summary: BNT162b2 vaccine remains highly effective and safe over the course of 6 months post-vaccination, with efficacy rates ranging from 86% to 100% across different demographics and risk factors for Covid-19. The vaccine also shows a high efficacy against severe disease, with particularly promising results observed in South Africa against the B.1.351 variant.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, Research & Experimental

Attenuated activation of pulmonary immune cells in mRNA-1273-vaccinated hamsters after SARS-CoV-2 infection

Michelle Meyer et al.

Summary: The study demonstrates that the mRNA-1273 vaccine is effective in hamsters against SARS-CoV-2, inducing robust neutralizing antibodies and reducing disease severity. It also shows the impact of the vaccine on immune cell infiltration, lymphocyte proportion, and antiviral responses conducive to lung health.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Article Biochemistry & Molecular Biology

A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity

Ren Yang et al.

Summary: SW0123 is a highly efficacious mRNA vaccine candidate with strong immunogenicity, inducing T cell and antibody responses, capable of neutralizing multiple variants, and providing effective protection in animal challenge experiments.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Add to Collection

Article Hematology

Acute lymphoblastic leukaemia patients treated with PEGasparaginase develop antibodies to PEG and the succinate linker

Robin Kloos et al.

BRITISH JOURNAL OF HAEMATOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

A new coronavirus associated with human respiratory disease in China

Fan Wu et al.

NATURE (2020)

Add to Collection

Review Pharmacology & Pharmacy

Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals

Gergely Tibor Kozma et al.

ADVANCED DRUG DELIVERY REVIEWS (2020)

Add to Collection

Review Immunology

Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies

Yujun Tang et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

Kizzmekia S. Corbett et al.

NATURE (2020)

Add to Collection

Article Multidisciplinary Sciences

Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice

Paul F. McKay et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Medicine, Research & Experimental

mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer

Gal Cafri et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Add to Collection

Review Immunology

Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections

Hanaa Ahmed-Hassan et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Article Pharmacology & Pharmacy

Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics

Carla B. Roces et al.

PHARMACEUTICS (2020)

Add to Collection

Review Materials Science, Multidisciplinary

PEGylated liposomes: immunological responses

Marwa Mohamed et al.

SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS (2019)

Add to Collection

Article Nanoscience & Nanotechnology

The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs

Akin Akinc et al.

NATURE NANOTECHNOLOGY (2019)

Add to Collection

Review Oncology

Spontaneously occurring cardiovascular lesions in commonly used laboratory animals

Eugene Herman et al.

CARDIO-ONCOLOGY (2019)

Add to Collection

Article Oncology

Gene therapy with RALA/iNOS composite nanoparticles significantly enhances survival in a model of metastatic prostate cancer

Cian M. McCrudden et al.

CANCER NANOTECHNOLOGY (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Comparative functional analysis of ribonuclease 1 homologs: molecular insights into evolving vertebrate physiology

Jo E. Lomax et al.

BIOCHEMICAL JOURNAL (2017)

Add to Collection

Article Chemistry, Medicinal

Amine promiscuity and toxicology analysis

Esther C. Y. Lee et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)

Add to Collection

Article Chemistry, Multidisciplinary

Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation

Peng Zhang et al.

JOURNAL OF CONTROLLED RELEASE (2016)

Add to Collection

Article Chemistry, Multidisciplinary

Development and characterization of self-assembling nanoparticles using a bio-inspired amphipathic peptide for gene delivery

Helen O. McCarthy et al.

JOURNAL OF CONTROLLED RELEASE (2014)

Add to Collection

Article Virology

Development of an improved microneutralization assay for respiratory syncytial virus by automated plaque counting using imaging analysis

Edyta Zielinska et al.

VIROLOGY JOURNAL (2005)

Add to Collection

Article Immunology

Impact of osmolality on burning sensations during and immediately after intramuscular injection of 0.5 ml of vaccine suspensions in healthy adults

P Nony et al.

VACCINE (2001)

Add to Collection

Article Chemistry, Physical

Polyelectrolyte titration: Theory and experiment

I Borukhov et al.

JOURNAL OF PHYSICAL CHEMISTRY B (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.